| VTR |
Report |
Normalized FFO/share (Q2 2026) |
BEAT |
pred ~$0.97 vs. cons $0.957 |
MEDIUM |
| VTR |
Report |
SHOP Same-Store NOI Growth YoY (Q2 2026) |
BEAT |
pred ~17.5-18% vs. cons 16.86% |
MEDIUM |
| VTR |
Report |
SHOP Same-Store Occupancy (Q2 2026) |
BEAT |
pred ~91.2-91.4% vs. cons 90.91% |
MEDIUM |
| VTR |
Guide |
Normalized FFO/share (FY2026) |
BETTER |
guide ~$3.91 mid vs. cons $3.878 |
MEDIUM |
| VTR |
Guide |
SHOP SS NOI Growth (FY2026) |
BETTER |
guide ~17% mid vs. cons 16.38% |
MEDIUM |
| VTR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| VTR |
Return |
5-day cumulative residual |
+3.0% (STABILIZE) |
STABILIZE — beat + raise are real but sector extended post-WELL sell-off; follow-through muted vs. prior Archetype A quarters |
MEDIUM |